Updates are available Correction dated 2026-02-02
Click to view Correction: https://doi.org/10.1186/s12974-026-03700-x
-
Authors
Nylund, Marjo
Lehto, Jussi
Matilainen, Markus
Rajander, Johan
Wahlroos, Saara
Sucksdorff, Marcus
Kuhlmann, Tanja
Airas, Laura
-
Funding
Funding for this research was provided by:
Research Council of Finland’s Flagship InFLAMES (337530, 357910 and 358823)
Research Council of Finland’s Flagship InFLAMES (337530, 357910 and 358823)
Research Council of Finland’s Flagship InFLAMES (337530, 357910 and 358823)
Suomen Kulttuurirahasto
University of Turku Drug Research Doctoral Programme
Research Council of Finland (330902)
Jane ja Aatos Erkon Säätiö (#220026)
National MS Society and the National Stem Cell Foundation (RFA-2203-39281)
- License Information
-
More Information
Article History
Received: 11 April 2025
Accepted: 15 July 2025
First Online: 7 August 2025
Change Date: 13 January 2026
Change Type: Update
Change Details: The given and family name of all the authors was corrected.
Change Date: 2 February 2026
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12974-026-03700-x
Declarations
:
: The authors declare no competing interests.
: The study protocol was approved by the Ethics Committee of the Hospital District of Southwest Finland (Dnro:76/180/2008 and Dnro:86/1800/2017). Written informed consent was obtained from all participants according to the principles of the Declaration of Helsinki. The study for postmortem neuropathological staining was approved by the Ethics Committee of the University of Münster (Ref: 2011-153-f-S).
